From pathways to targets: understanding the mechanisms behind polyglutamine disease.
about
Applications of Induced Pluripotent Stem Cells in Studying the Neurodegenerative DiseasesIntrinsic protein disorder in histone lysine methylation.Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph DiseaseNeuronal Mitophagy in Neurodegenerative DiseasesFragment based G-QSAR and molecular dynamics based mechanistic simulations into hydroxamic-based HDAC inhibitors against spinocerebellar ataxia.The emerging role of the first 17 amino acids of huntingtin in Huntington's diseaseProteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.Ataxin-1 regulates the cerebellar bioenergetics proteome through the GSK3β-mTOR pathway which is altered in Spinocerebellar ataxia type 1 (SCA1).Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer.Peripheral Oxidative Stress Biomarkers in Spinocerebellar Ataxia Type 3/Machado-Joseph DiseaseKaryopherin α-3 is a key protein in the pathogenesis of spinocerebellar ataxia type 3 controlling the nuclear localization of ataxin-3.Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3Proteome-scale relationships between local amino acid composition and protein fates and functions
P2860
Q26799331-370588B0-F76E-4B2B-B0B1-F5CCBCC736F6Q27335553-85C4A7E3-DB09-48FC-9A3E-41FB49681B4CQ28550502-3BE63713-D4E6-41BF-B4B4-63F8AC2AF0B6Q29248361-44DB73AC-B313-400C-9F99-F3501155E3E1Q35824698-76DDCB4D-9896-468B-832D-278D4066A266Q36110838-86066B9D-35A2-4ECF-8AB6-8A4680F91CF5Q39124557-6061C1F3-B896-4251-8E07-702E24CC2BB5Q39552099-7B3F76CE-FC25-46C5-A1BA-C718257EEA5FQ40047888-F815F602-8D78-45E9-AC34-2E918DA27CABQ41882102-86D9CFFE-9055-4828-8B47-93DA7B395F41Q51767599-E8F5866F-C834-498F-8DFB-F677EEF35380Q58575955-2BE2EAAD-FDAB-4FCE-BB2A-3F80BCFC8AB8Q58622946-13546110-3F1F-46AA-AEDC-FAEED01E70D9
P2860
From pathways to targets: understanding the mechanisms behind polyglutamine disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
From pathways to targets: understanding the mechanisms behind polyglutamine disease.
@en
type
label
From pathways to targets: understanding the mechanisms behind polyglutamine disease.
@en
prefLabel
From pathways to targets: understanding the mechanisms behind polyglutamine disease.
@en
P2860
P50
P356
P1476
From pathways to targets: understanding the mechanisms behind polyglutamine disease
@en
P2093
Anna Sergeevna Sowa
P2860
P304
P356
10.1155/2014/701758
P407
P577
2014-09-21T00:00:00Z